Phenytoin Toxicity in a Patient Receiving 5-Fluorouracil–Based Chemotherapy for Metastatic Colorectal Cancer

Sara M. Kuruvilla; Som D. Mukherjee

doi:10.3747/co.v18i6.839

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Letter

1 December 2011

Phenytoin Toxicity in a Patient Receiving 5-Fluorouracil–Based Chemotherapy for Metastatic Colorectal Cancer

and

Department of Oncology, McMaster University Juravinski Cancer Centre, Hamilton, ON, Canada

Author to whom correspondence should be addressed.

Curr. Oncol.2011, 18(6), 264-265;https://doi.org/10.3747/co.v18i6.839

Version Notes

Order Reprints

Abstract

In addition to chemotherapeutics, cancer patients often take a variety of medications for reasons related and unrelated to their underlying cancer [...].

Keywords:

phenytoin toxicity; folfiri; chemotherapy; colorectal cancer; 5-fluorouracil

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Mixing Drinks and Concocting Troubles